Insmed Incorporated
INSM
$123.74
-$2.59-2.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 39.06% | 15.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 39.06% | 15.96% | |||
| Cost of Revenue | 41.74% | 7.24% | |||
| Gross Profit | 38.57% | 17.72% | |||
| SG&A Expenses | 0.08% | 16.37% | |||
| Depreciation & Amortization | 0.00% | 7.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.06% | -1.42% | |||
| Operating Income | 49.42% | 19.79% | |||
| Income Before Tax | 92.98% | 50.42% | |||
| Income Tax Expenses | 27.58% | -5.54% | |||
| Earnings from Continuing Operations | 91.90% | 50.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 91.90% | 50.21% | |||
| EBIT | 49.42% | 19.79% | |||
| EBITDA | 50.67% | 19.98% | |||
| EPS Basic | 91.98% | 50.63% | |||
| Normalized Basic EPS | 47.30% | 19.31% | |||
| EPS Diluted | 91.99% | 50.59% | |||
| Normalized Diluted EPS | 47.30% | 19.31% | |||
| Average Basic Shares Outstanding | 0.87% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.87% | 0.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||